Spots Global Cancer Trial Database for Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Official Title: Phase II Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Study ID: NCT00505063

Conditions

Childhood Cancer

Multiple Diseases

Interventions

Immunization Schedule patients <7 years.

Immunization Schedule patients > or = to 7 years and <11 years of age

Immunization Schedule patients > or = to 11 years of age

Study Description

Brief Summary: This study will look at your body's response to the new immunizations. We want to see how well they will protect you. Immunization is the same as vaccination. Our goal is to protect you as much as we can. We do not want you to have the measles, mumps, or whooping cough. We are doing the study because there is no standard way to re-immunize people after cancer treatments.

Detailed Description: